| Literature DB >> 26338697 |
Shaofu Qiu1, Peng Li1, Hongbo Liu1, Yong Wang1, Nan Liu1, Chengyi Li1, Shenlong Li1, Ming Li2, Zhengjie Jiang3, Huandong Sun3, Ying Li2, Jing Xie1, Chaojie Yang1, Jian Wang1, Hao Li1, Shengjie Yi1, Zhihao Wu1, Leili Jia1, Ligui Wang1, Rongzhang Hao1, Yansong Sun1, Liuyu Huang1, Hui Ma4, Zhengquan Yuan1, Hongbin Song1.
Abstract
From December 2012 to February 2013, two outbreaks of acute respiratory disease caused by HAdV-7 were reported in China. We investigated possible transmission links between these two seemingly unrelated outbreaks by integration of epidemiological and whole-genome sequencing (WGS) data. WGS analyses showed that the HAdV-7 isolates from the two outbreaks were genetically indistinguishable; however, a 12 bp deletion in the virus-associated RNA gene distinguished the outbreak isolates from other HAdV-7 isolates. Outbreak HAdV-7 isolates demonstrated increased viral replication compared to non-outbreak associated HAdV-7 isolate. Epidemiological data supported that the first outbreak was caused by introduction of the novel HAdV-7 virus by an infected recruit upon arrival at the training base. Nosocomial transmission by close contacts was the most likely source leading to onset of the second HAdV-7 outbreak, establishing the apparent transmission link between the outbreaks. Our findings imply that in-hospital contact investigations should be encouraged to reduce or interrupt further spread of infectious agents when treating outbreak cases, and WGS can provide useful information guiding infection-control interventions.Entities:
Mesh:
Year: 2015 PMID: 26338697 PMCID: PMC4559894 DOI: 10.1038/srep13617
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Cases of confirmed and probable HAdV-7 infections during the two outbreaks.
A total of 946 persons were affected during the outbreaks. We collected 328 and 80 nasopharyngeal specimens from the two outbreak patients, respectively, and 323 HAdV-7 isolates were identified by PCR assays and viral culture.
Clinical characteristics of the hospitalized patients from the two outbreaks#.
| Symptoms or signs | ||
| Fever | ||
| Any-no. (%) | 319 (99.4) | 42 (100.0) |
| Subgroup-no. (%) | ||
| 37.3–38.0 °C | 10 (3.1) | 0 |
| 38.1–39.0 °C | 131 (40.8) | 20 (47.6) |
| >39.0 °C | 178 (55.5) | 22 (52.4) |
| Maximal temperature (°C), mean | 39.2 ± 0.6 | 39.4 ± 0.7 |
| Duration of fever, median (range), days | 4.0 (1–20) | 4.0 (2–11) |
| Cough | 304 (94.7) | 40 (95.2) |
| Throat congestion | 296 (92.2) | 36 (85.7) |
| Sore throat | 246 (76.6) | 32 (76.2) |
| Sputum production -no./total no. (%) | 234/321 (72.9) | 34/42 (81.0) |
| Yellow sputum | 145/234 (62.0) | 24/34 (70.6) |
| White sputum | 89/234 (38.0) | 10/34 (29.4) |
| Blood-streaked sputum | 28/234 (12.0) | 6/34 (17.6) |
| Swelling of tonsils | 211 (65.7) | 24 (57.1) |
| Fatigue | 139 (43.3) | 21 (50.0) |
| Pharyngeal lymphoid follicular hyperplasia | 126 (39.3) | 15 (35.7) |
| Purulent exudate on the tonsil | 102 (31.8) | 12 (28.6) |
| Rhinorrhea | 79 (24.6) | 9 (21.4) |
| Myalgia | 76 (23.7) | 8 (19.0) |
| Headache | 64 (19.9) | 8 (19.0) |
| Dizziness | 61 (19.0) | 5 (11.9) |
| Shortness of breath | 54 (16.8) | 8 (19.0) |
| Chest pain | 51 (15.9) | 9 (21.4) |
| Diarrhea | 30 (9.3) | 5 (11.9) |
| Nasal congestion | 29 (9.0) | 2 (4.8) |
| Chill | 23 (7.2) | 2 (4.8) |
| Enlargement of lymph nodes | 20 (6.2) | 4 (9.5) |
| Abdominal pain | 19 (5.9) | 3 (7.1) |
| Bronchitis | 18 (5.6) | 1 (2.4) |
| Nausea | 12 (3.7) | 5 (11.9) |
| Vomiting | 8 (2.5) | 1 (2.4) |
| Palpitation | 3 (0.9) | 1 (2.4) |
| Submandibular lymphadenitis | 3 (0.9) | 0 |
| Tinnitus, earache | 3 (0.9) | 0 |
| Skin rash | 2 (0.6) | 1 (2.4) |
| Convulsion, coma | 2 (0.6) | 0 |
| Testicular pain | 2 (0.6) | 0 |
| Clinical outcome | ||
| Hospitalization, no./total no. (%) | 321/858 (37.4) | 42/88 (47.7) |
| Time from illness onset to hospitalization, median (range), days | 3.0 (1–36) | 3.0 (1–7) |
| Duration of hospitalization, median (range), days | 10.0 (6–25) | 9.0 (7–25) |
| Pneumonia, no./total no. (%) | 108/321 (36.2) | 16/42 (38.1) |
| Admission to an intensive care unit | 37/108 (34.3) | 4/16 (25.0) |
| Heart injury | 14/108 (13.0) | 2/16 (12.5) |
| Liver injury | 11/108 (10.2) | 3/16 (18.8) |
| Gallbladder injury | 3/108 (2.8) | 1/16 (6.3) |
| Meningitis irritation | 2/108 (1.9) | 0 |
| Secondary infections | 10/108 (9.3) | 2/16 (12.5) |
#In this study 256 patients were confirmed as HAdV-7 positive infections among the 321 hospitalized patients by PCR and viral culture.
*In this study continuous variables were summarized as means (±SD) or medians (range).
Laboratory and radiographic findings of the hospitalized patients from the two outbreaks†.
| Variable | ||
|---|---|---|
| WBC count | ||
| Median (range), 109 cells/liter | 10.4 (3.1–25) | 10.5 (3.4–15.4) |
| >10 × 109 cells/L, no. (%) | 156 (52.3) | 21 (50.0) |
| <4 × 109 cells/L, no. (%) | 23 (7.7) | 3 (7.1) |
| RBC count, median (range), 1012 cells/liter | 4.46 (3.45–6.0) | 4.31 (3.47–4.97) |
| Platelet count, median (range), 109 cells/liter | 213.2 (129–414) | 223.5 (137–414) |
| Hemoglobin, median (range), g/liter | 133 (98–312) | 134 (102–156) |
| Glucose, >6.2 mmol/liter, no. (%) | 76 (25.5) | 9 (21.4) |
| Creatine Kinase, >200 U/liter, no. (%) | 97 (32.6) | 18 (42.9) |
| Creatine kinase MB fraction, >25 U/liter, no. (%) | 85 (28.5) | 18 (42.9) |
| Lactate dehydrogenase, >250 U/liter, no. (%) | 39 (13.1) | 5 (11.9) |
| Aspartate aminotransferase, >40 U/liter, no. (%) | 43 (14.4) | 6 (14.3) |
| Alanine aminotransferase, >40 U/liter, no. (%) | 41 (13.8) | 6 (14.3) |
| Total bilirubin, >17.1 μmol/liter, no. (%) | 27 (9.1) | 4 (9.5) |
| Uric acid, >416 umol/liter, no. (%) | 17 (5.7) | 2 (4.8) |
| Creatinine, >133 μmol/liter, no. (%) | 13 (4.4) | 2 (4.8) |
| Potassium | ||
| median (range), mmol/liter | 3.76 (3.0–5.61) | 3.75 (3.18–4.57) |
| <3.5 μmol/liter, no./total no. (%) | 32 (10.7) | 8 (19.0) |
| Sodium, median (range), mmol/liter | 138 (132–143) | 138 (131–142) |
| Erythrocyte sedimentation rate, >15 mm/hr, no. (%) | 79 (26.5) | 20 (47.6) |
| C-reactive protein, >10 mg/liter — no. (%) | 117 (39.3) | 15 (35.7) |
| Abnormalities on electrocardiogram, no./total no. (%) | 101/298 (33.9) | 16/42 (38.1) |
| Sinus arrhythmia | 60/101 (59.4) | 11/16 (68.8) |
| High left ventricular voltage | 27/101 (26.7) | 5/16 (31.3) |
| Bundle branch block | 3/101 (3.0) | 1/16 (6.3) |
| T-wave change | 7/101 (6.9) | 0 |
| Ventricular premature contraction | 5/101 (5.0) | 1/16 (6.3) |
| Abnormalities on chest radiograph and CT, no./total no. (%) | 108/298 (36.2) | 16/42 (38.1) |
| Local patchy shadowing | 101/108 (93.5) | 15/16 (93.8) |
| Ground-glass opacities | 3/108 (2.8) | 0 |
| Pulmonary nodule | 6/108 (5.6) | 1/16 (6.3) |
| Mediastinal lymphadenectasis | 5/108 (4.6) | 2/16 (12.5) |
| Consolidation | 4/108 (3.7) | 1/16 (6.3) |
| Involvement of left lung | 11/108 (10.2) | 1/16 (6.3) |
| Involvement of right lung | 41/108 (38.0) | 4/16 (25.0) |
| Involvement of both lungs | 56/108 (51.9) | 11/16 (68.8) |
†The clinical laboratory data on admission were available for 298 patients from the Xiangyang outbreak.
Figure 2Timeline of critical events and nosocomial transmission for the index cases.
Index case C was hospitalized due to a training injury from February 3 to 8, 2013. During his hospitalization, there were also about 70 patients hospitalized in the Xiangyang affiliated hospital from the Base A outbreak (Xiangyang). All cases were housed in the same in-patient building. Index case C had close contact with Index case B, a confirmed HAdV-7 case from the Xiangyang outbreak. They reported verbal contact twice for about half an hour on February 5 and 7, 2013, respectively. After 5 days of hospitalization, he returned to the training base B (Jingmen) on February 8, 2013, and took part in the normal training without isolation for medical observation. On February 11, 2013, he developed symptoms of ARD with fever (maximum temperature 39·0 °C), sore throat, cough and headache. A nasopharyngeal sample collected from this patient was detected positive for HAdV-7 by PCR sequencing on February 22, 2013. Thereafter, 5 roommates consecutively had ARD symptoms. These investigations revealed that nosocomial transmission by close contact contributed to the introduction of HAdV-7 into the training base B (Jingmen), indicating the potential transmission link between the two outbreaks. This figure including the drawings of people was drawn by the author Shaofu Qiu.
Figure 3Phylogenetic analysis of the outbreak isolates based on WGS and individual genes.
Panels (A–D) represent the phylogenetic trees of the whole-genome, and individual entire hexon, fiber and penton genes, respectively. Outbreak strains are highlighted in circle (), and the local strain CDC 228 from Xiangyang City is indicated in triangle (). Bootstrap analysis was performed with 1,000 replicates. Representative HAdV strains with GenBank accession numbers are included in the phylogenetic trees, and they are also shown in Table S2.
Figure 4Phylogenetic analysis and pairwise alignment of the outbreak isolates based on DNA polymerase and VA RNA.
Panels (A,C) represent the phylogenetic trees of DNA polymerase and VA RNA genes, respectively. Panels (B,D) represent the pairwise alignment analyses of the outbreak strains based on the DNA polymerase amino acid sequences and VA RNA genes, respectively.
Comparative genomic analysis of the outbreak strains with the reference strains and the local strain CDC228§.
| ITR | 518 | inverted terminal repeat | Insertion of T | — | — |
| E1A | 815 | 28 kDa protein | — | — | T→G (W→L) |
| 1444 | — | — | A→G | ||
| IVa2 | 4133 | — | — | — | C→T |
| E2B | 5517 | DNA polymerase | G→C (D→E) | — | — |
| 7494 | — | — | G→T (L→I) | ||
| 9168 | preterminal DNA-binding protein | — | — | C→T | |
| 9327 | — | — | G→T | ||
| L1 | 10698–10709 | Virus-associated RNA II | — | — | Deletion of GTTGCGGTGTGC |
| 10734 | — | — | G→A | ||
| 10816 | — | Insertion of T | Insertion of T | ||
| 10830 | G→A | — | — | ||
| L2 | 14594 | Penton | T→C (V→A) | — | — |
| 14854 | — | — | A→G (N→D) | ||
| L3 | 17871 | Protein VI precursor | — | — | C→G (P→A) |
| L4 | 24298 | hexon-assembly associated protein | C→T | — | — |
| 24904 | — | — | T→C | ||
| E3 | 27799 | 16.1 kDa protein | — | — | C→T (P→S) |
| Non-coding Region | 29950 | — | — | — | Insertion of T |
| E4 | 32450 | E4 | — | — | T→C (N→D) |
| 33155 | 32 kDa protein | G→T (P→Q) | — | — | |
| Non-coding Region | 34904 | — | — | — | G→A |
| ITR | 35125 | inverted terminal repeat | — | — | C→A |
“–” means no change or not applicable.
§The reference genomes include the HAdV-7 strains DG01_2011 (KC440171) and 0901HZ/ShX/2009 (JF800905). Outbreak strains mean the nine HAdV-7 outbreak strains.
&Synonymous mutation.
Figure 5Replication kinetic of a representative outbreak-associated isolate XY1 relative to non-outbreak-associated isolate CDC228.
Since the outbreak isolates shared an indistinguishable genome content, a representative outbreak-associated isolate XY1 was used to evaluate the viral replication. The isolate XY1 was recovered from the first case (Index case A) from the Xiangyang outbreak, and the on-outbreak-associated isolate CDC228 was recovered from a sporadic ARD patient from Xiangyang City. Virus titers were determined in Hep-2 cells by measuring the 50% tissue culture infectious dose (TCID50).